Cyclic AMP-response element modulator ␣ (CREM␣) is a transcription factor that is highly related to cAMPresponse element-binding protein (CREB) but represses cAMP-induced gene expression from simple artificial promoters containing a cAMP-response element (CRE). CREM␣ lacks two glutamine-rich Q regions that, in CREB, are thought to be necessary for transcriptional activation. Nevertheless, protein kinase A stimulation induces CREM␣ to activate the complex native promoter in the phosphoenolpyruvate carboxykinase (PEPCK) gene. To study this phenomenon in the absence of protein kinase A stimulation, we introduced a mutation into CREM␣ to allow constitutive binding to the coactivator CREB-binding protein. This mutant, CREM␣ DIEDML , constitutively activated the PEPCK promoter. By engineering the leucine zipper regions of CREM␣ DIEDML and CREB DIEDML to direct their patterns of dimerization, we found that only CREM␣ DIEDML homodimers fully activated the PEPCK promoter. By using a series of deletion and block mutants of the PEPCK promoter, we found that activation by CREM␣ DIEDML depended on the CRE and two CCAAT/enhancer-binding protein (C/EBP) sites. A dominant negative inhibitor of C/EBP, A-C/EBP, suppressed activation by CREM␣ DIEDML . Furthermore, a GAL4-C/EBP␣ fusion protein and CREM␣ DIEDML cooperatively activated a promoter containing three GAL4 sites and the PEPCK CRE. Thus, we propose that the C/EBP sites in the PEPCK promoter allow CREM␣ to activate transcription despite its lack of Q regions.
specifically to CREs (TGACGTCA) via their conserved C-terminal basic leucine zipper (bZIP) domains (2) . Three domains encoded by the CREM and CREB genes contribute to transcriptional activation: the kinase-inducible domain (KID) and two glutamine-rich regions designated as Q-1 and Q-2 (3). Phosphorylation of a serine residue within the KID by PKA allows CREB and CREM to bind to the coactivator CREB-binding protein (CBP) (4, 5) . The Q regions are thought to interact with components of the basal transcriptional machinery (6) . In CREB, the deletion of the Q-2 region prevents transcriptional activation (7) . Moreover, CREM isoforms that lack Q regions have been shown to act as repressors of cAMP-induced transcription (2) . These data have lead to the hypothesis that Q regions are required for CREB-mediated transcriptional activation.
The CREM␣ isoform contains a KID but lacks both Q regions (2) . CREM␣ represses transcription induced by PKA-activated CREB at a minimal promoter containing the somatostatin CRE (2) . This repression may be mediated by CREB-CREM␣ heterodimers, which are only weak activators, or by CREM␣ homodimers that cannot activate transcription at the somatostatin CRE (8) . These data form the bulk of the evidence for the hypothesis that CREM␣ is a repressor of cAMP-induced transcription. However, tests of this hypothesis at native promoters have produced mixed results. For example, CREM␣ has been shown to be a repressor at the native c-fos and insulin promoters (9, 10) but activates transcription from the PEPCK promoter (11) .
The PEPCK gene has a complex promoter that contains multiple elements to allow regulation by a variety of hormonetriggered signaling pathways and tissue-specific factors (reviewed in Ref. 12 ). In addition, cAMP induces transcription via multiple PEPCK promoter elements (13) . Several transcription factors have been proposed to be involved in the cAMP response: 1) CREB and CREM proteins, which can bind to a nonconsensus CRE (TTACGTCA) ϳ85 base pairs upstream of the PEPCK transcription start site; 2) CCAAT/enhancer-binding proteins (C/EBPs), which can bind to the CRE and three upstream sites; and 3) c-Jun, which can bind within the region encompassing the C/EBP sites. All of the above factors are necessary for the full cAMP response at the PEPCK promoter, suggesting that cooperativity among the factors is the crucial aspect of the activation mechanism.
In this paper, we examined the mechanism of activation of PEPCK transcription by CREM␣. The most direct way to do this was to study the activity of CREM␣ in isolation from other effectors of PKA at the PEPCK promoter. Thus, we developed a constitutively active PKA-independent mutant of CREM␣, CREM␣ DIEDML , that contains a six-amino acid substitution within the KID (RRPSYR to DIEDML). In the related CREB protein, this substitution has been shown to confer constitutive binding to CBP, resulting in constitutive transcriptional activity (14) . We tested whether the CREM␣ mutant could activate transcription from the PEPCK promoter as a homodimer or whether heterodimerization with another bZIP factor is required. Also, we used a fluorescence polarization equilibrium binding assay to demonstrate that CREM␣ binds with high affinity to the PEPCK CRE. Finally, we used the CREM␣ mutant to ask whether its transcriptional activity depended on other factors that bind to the PEPCK promoter. Our findings led us to propose that the recruitment of CBP to CREM␣ homodimers can result in the activation of complex promoters containing binding sites for C/EBP.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfections-Hep G2 cells were grown as described previously (11) except that heat-inactivated fetal bovine serum was used in most experiments. Cells were seeded onto five 10-cm plates (for experiments shown in Figs. 1 (Fig. 2B only) , or FuGENE 6 (Roche Molecular Biochemicals) (Figs. 3 and 6A only) according to the manufacturer's instructions. All transfection methods produced equivalent results. Cells were harvested after incubation for 48 h. In the experiment shown in Fig. 2B , cells were serum-starved for the final 16 h of incubation before harvesting. Reporter gene activities were determined as described previously (14) . Relative luciferase (LUC) or chloramphenicol acetyltransferase (CAT) activities were determined by normalization to ␤-galactosidase activity (values are given as the mean Ϯ S.D. or the mean Ϯ S.E. in Fig. 3 ). All experiments were repeated at least three times.
Plasmids-The reporter genes Ϫ490PEPCK-LUC, fos-LUC, and Ϫ109G3-CAT have been described previously (15) (16) (17) . Block mutants of Ϫ490PEPCK-LUC were made with the QuikChange site-directed mutagenesis kit (Stratagene) using mutations described previously (13) . Mouse CREM␣ (2) was cloned into the expression vector pRcRSV (Invitrogen). RSV-CREB and the DIEDML mutation have been described previously (14) . The ZIP3 and ZIP4 mutations were made in CREM␣ DIEDML and CREB DIEDML with the QuikChange kit. In CREB ZIP3, lysine replaces glutamate 319, and glutamate replaces lysine 333. In CREB ZIP4, glutamate replaces arginine 314, and lysine replaces glutamate 328. In CREM␣ ZIP3, lysine replaces glutamate 207, and glutamate replaces lysine 221. In CREM␣ ZIP4, glutamate replaces arginine 202, and lysine replaces glutamate 216. GAL4-C/EBP␣ is G␣2 as described previously (17) . A-C/EBP is described (see Ref. 18 ). RSV-␤-GAL was used for normalization for transfection efficiency.
Fluorescence Polarization Measurements-Fluorescence polarization measurements were made as described previously (14) with the following exceptions. The 5Ј-fluoresceinated oligonucleotide corresponding to the top strand of the PEPCK CRE (5Ј-CCTTACGTCAGCCCCCT-GACGTAAGG-3Ј) was purchased from Life Technologies, Inc. The CRE is in boldface. The binding reactions in 1 ml of solution contained 1 nM fluoresceinated oligonucleotide in 25 mM Tris-HCl, pH 7.6, 50 mM NaCl, 0.5 mM EDTA, 5% glycerol, 6 g of bovine serum albumin, and 10 mM MgCl 2 . C/EBP␣ protein was a generous gift of Dr. Peter Johnson (Frederick Cancer Research and Development Center, Frederick, MD).
Glutathione S-Transferase Pull-down Assay-The binding of CBP in HeLa nuclear extracts to glutathione S-transferase-CREM␣ DIEDML-(1-171) was assayed as described previously (19) , using CBP C-20 antibody (Santa Cruz Biotechnology).
RESULTS
Cardinaux et al. (14) recently developed a constitutively active CREB mutant (CREB DIEDML ). This mutant (Fig. 1A) was made by replacing six residues (RRPSYR, which includes S 133 ) from the KID domain of CREB with six residues (DIEDML) from the sterol response element-binding protein, a transcription factor that binds CBP in the absence of phosphorylation. Whereas wild-type CREB must be phosphorylated at Ser 133 to bind to CBP, the substitution of the DIEDML motif conferred constitutive phosphorylation-independent binding. CREB DIEDML activated transcription from CRE-containing reporter genes under basal conditions in a variety of cell types.
FIG. 4. CREM␣ DIEDML activates the PEPCK promoter as a homodimer.
A, ZIP3 and ZIP4 mutants of the CREB bZIP. Mutations are depicted in the context of the crystal structure of the CREB bZIP dimer bound to the somatostatin CRE (21) . The left panel shows the wild-type dimer. The ZIP3 and ZIP4 mutations should result in charge repulsions in ZIP3/ZIP3 and ZIP4/ZIP4 homodimers (middle two panels) and in heterodimers of ZIP3 or ZIP4 with endogenous CREB family proteins. In contrast, the favorable electrostatic interactions of the wild-type zippers should be present in the ZIP3/ZIP4 heterodimer (right panel). Analogous mutations were made in the highly related CREM bZIP. B, activation of the PEPCK promoter by CREB DIEDML and CREM␣ DIEDML ZIP3 and ZIP4 mutants. In this panel, CREM and CREB refer to CREM␣ DIEDML and CREB DIEDML . Hep G2 cells were transfected with 100 ng of PEPCK-LUC reporter, 100 ng of CREB DIEDML or CREM␣ DIEDML , and 50 ng each of ZIP3 or ZIP4 mutant.
Thus, the activity of CREB DIEDML could be studied in isolation from other activities stimulated by PKA. We sought to develop a similar mutant of CREM␣. Because the relevant regions of CREB and CREM␣ are identical, we substituted the residues DIEDML for RRPSYR in CREM␣ to generate the mutant CREM␣ DIEDML . We tested the activity of this mutant with a reporter gene driven by 490 base pairs of the PEPCK promoter upstream from the transcription start site (Ϫ490 PEPCK). It has been demonstrated that the PEPCK promoter can be activated by wild-type CREM␣ in the presence of cotransfected PKA catalytic subunit in the Hep G2 human liver-derived cell line (11) . Fig. 1B shows that, in the absence of cotransfected PKA, CREM␣ DIEDML produced an ϳ4 -5-fold activation of the PEPCK promoter, whereas wild-type CREM␣ produced only marginal activation. We also performed a glutathione S-transferase pull-down assay to confirm that CREM␣ DIEDML binds CBP (data not shown). Thus, CREM␣ DIEDML constitutively activates PEPCK transcription by recruiting CBP.
We next tested the efficacy and specificity of CREM␣ DIEDML . To measure efficacy, we compared the ability of CREB DIEDML and CREM␣ DIEDML to activate the PEPCK promoter. Fig. 2A shows that CREM␣ DIEMDL produced a slightly greater activation than CREB DIEDML at all doses. Thus, despite lacking the Q regions, CREM␣ appears to be a better activator than CREB in the context of the PEPCK promoter. To test specificity, we measured the activity of CREM␣ DIEDML at the c-fos promoter. Fig. 2B shows that CREM␣ DIEDML had little effect on c-fos reporter gene transcription, whereas CREB DIEDML produced ϳ9-fold activation. Thus, it appears that CREM␣ DIEDML induces transcription only from promoters at which wild-type CREM␣ can produce activation. These data suggest that CREM␣ DIEDML can be an effective and specific reagent for testing the mechanism of transcriptional activation by CREM␣.
In principle, the differences in the activity of CREM␣ DIEDML and CREB DIEDML at the PEPCK promoter could be due to differences in their ability to bind the PEPCK CRE. Electrophoretic mobility shift assays have demonstrated that CREM␣, CREB, and C/EBP␣ can all bind to the PEPCK CRE (11, 15) , but the quantitative accuracy of these assays may be compromised by the separation of bound and free transcription factors during gel electrophoresis. Thus, we used a fluorescence polarization assay (20) to determine the affinities of these interactions under equilibrium conditions in solution. Fig. 3 shows that CREM␣, CREB, and C/EBP␣ all bind to the PEPCK CRE with K d ϭ ϳ1 nM. Thus, all three transcription factors have the ability to interact with the PEPCK CRE with similarly high affinity.
Although it has been presumed that the transfection of CREM␣ DIEDML into Hep G2 cells results in the formation of stable homodimers, it is possible that CREM␣ DIEDML heterodimerizes with endogenous CREB. To test the ability of CREM␣ DIEDML homodimers and heterodimers to activate the PEPCK promoter, we made two leucine zipper mutants of CREM␣ DIEDML and CREB DIEDML termed ZIP3 and ZIP4. ZIP3 and ZIP4 contain mutations that are designed to cause them to preferentially associate as heterodimers (8) . The mechanism of heterodimerization between ZIP3 and ZIP4 mutants is ex- plained in Fig. 4A , which shows these mutations in the context of the crystal structure of the CREB bZIP⅐CRE complex (21) . As indicated, the substitution of the charged residues in the e and g positions of the leucine zipper results in electrostatic repulsion except in the context of the ZIP3/ZIP4 heterodimer. Thus, by cotransfecting the ZIP3 and ZIP4 mutants, we can ensure the formation of the intended dimers. Fig. 4B shows that only the CREM␣ DIEDML homodimer (CREM␣ DIEDML ZIP3/ CREM␣ DIEDML ZIP4) can activate the PEPCK promoter to the same degree as CREM␣ DIEDML containing a wild-type leucine zipper. CREM␣ DIEDML /CREB DIEDML heterodimers (CREM␣ DIEDML ZIP3/CREB DIEDML ZIP4 or CREM␣ DIEDML ZIP4/CREB DIEDML ZIP3) produced only marginal activation. Thus, CREM␣ can activate the PEPCK promoter as a homodimer. Therefore, the requirement of Q regions for CREMmediated transcriptional activation is highly dependent on promoter context.
One possible explanation for the context specificity of the function of CREM␣ is that it can only activate transcription in cooperation with other factors. The Ϫ490 PEPCK promoter contains three groups of cis-regulatory elements (Fig. 5A ) (reviewed in Ref. 12). To determine which factors cooperate with CREM␣ to produce activation, we tested the ability of CREM␣ DIEDML to activate a series of PEPCK promoter deletion mutants. Fig. 5B shows that deleting group 3 elements had no effect on reporter gene expression levels produced by CREM␣ DIEDML . In contrast, deleting both groups 3 and 2 greatly diminished activation by CREM␣ DIEDML . Moreover, CREM␣ DIEDML did not activate a PEPCK promoter mutant lacking all regulatory elements upstream of the CRE. Thus, CREM␣ DIEDML must cooperate with transcription factors that bind to the group 2 region to produce full activation of the PEPCK promoter.
Five cis-regulatory elements have been identified in the group 2 region of the PEPCK promoter (Fig. 5A ) (reviewed in Ref. 12), three of which (P3I, P3II, and P4) are required for full activation by cAMP (13) . To determine which of these elements binds factors that cooperate with CREM␣ DIEDML , we used block mutants that were previously characterized (13) . The block mutations prevent the binding of rat liver nuclear proteins and greatly diminish the response of the promoter to the catalytic subunit of PKA. Fig. 6 shows the effect of the block mutations on the ability of CREM␣ DIEDML to activate the PEPCK promoter. Block mutation of the P3I site partially reduced activation by CREM␣ DIEDML . The activation was further reduced when both the P3I and P4 sites were mutated. In contrast, block mutations in the P2 and P3II sites had little effect on the activation by CREM␣ DIEDML (data not shown). Thus, CREM␣ activates transcription in cooperation with factors that bind to the P3I and P4 sites of the PEPCK promoter.
The only transcription factors known to bind the P3I and P4 sites in the PEPCK promoter are members of the C/EBP family (22) . To test whether C/EBP proteins are required for activation of the PEPCK promoter by CREM␣ DIEDML , we used a dominant negative inhibitor of C/EBP, A-C/EBP (18) . shows that A-C/EBP suppressed the stimulatory effect of CREM␣ DIEDML . Thus, C/EBP proteins appear to be required for the activation of the PEPCK promoter by CREM␣. Of the various C/EBP proteins, C/EBP␣ has been reported to be most critical for activation by cAMP (23) . To test whether C/EBP␣ could cooperate with CREM␣ DIEDML , we used a reporter gene driven by three binding sites for the yeast transcription factor GAL4 and a partial PEPCK promoter containing only the CRE (Fig. 7B) (termed Ϫ109G3 in Ref. 17) . Fig. 7C shows that Ϫ109G3 was activated to a greater degree by the combination of both Gal4-C/EBP␣ and CREM␣ DIEDML than by each factor alone. These data suggest that the factor that cooperates with CREM␣ to allow activation of the PEPCK promoter is C/EBP␣.
DISCUSSION
In this study, we examined the mechanism by which CREM␣ activates PEPCK transcription. To do this, we developed a constitutively active mutant of CREM␣, CREM␣ DIEDML . CREM␣ DIEDML probably functions by constitutive binding to CBP as does the related mutant, CREB DIEDML (14) . The phosphorylation-independent activity of these mutants allowed us to study their activity in isolation from other effectors of PKA at the PEPCK promoter (e.g. AP1) (24, 25) . In principle, the activation of PEPCK transcription by CREM␣ DIEDML (Fig. 1 ) could have been produced by CREM␣ DIEDML homodimers or by heterodimers of CREM␣ DIEDML with endogenous unphosphorylated CREB. In the latter case, the unphosphorylated CREB molecule could provide the Q regions capable of contacting the basal transcriptional machinery, which has been proposed to be a requirement for CREB-mediated transcriptional activation. We tested these two possibilities by engineering the leucine zipper regions of CREM␣ DIEDML and CREB DIEDML to direct their pattern of dimerization. Also, we tested whether activation of PEPCK transcription by CREM␣ DIEDML depended on cooperative interactions with other factors that bind the PEPCK promoter.
Our finding that CREM␣ homodimer activates the PEPCK promoter (Fig. 4C) shows that Q regions are not always necessary for transcriptional activation. Indeed, Q regions appear to be detrimental to the activation at the PEPCK promoter. CREB DIEDML is slightly less active than CREM␣ DIEDML ( Fig.  2A) , and CREM␣ DIEDML /CREB DIEDML heterodimers produce only marginal activation (Fig. 4C) . In contrast, the importance of these regions at some promoters is indicated by the observation that deletion of the Q-2 region eliminates activation of a somatostatin CRE reporter gene by CREB (7) . Moreover, we found that the c-fos promoter could not be activated by CREM␣ DIEDML . Thus, the function of the Q regions appears to be highly dependent on promoter context. CREM␣ DIEDML only marginally activated transcription from a promoter containing just the PEPCK CRE (Fig. 5) or a PEPCK promoter with mutations in two C/EBP sites (Fig. 6) . Thus, the recruitment of CBP by CREM␣ is not sufficient for activation of the PEPCK promoter. Rather, it appears that CREM␣ must cooperate with C/EBP␣ to achieve full activation (Fig. 7) . Perhaps C/EBP␣ also interacts with CBP, either directly or through an intermediate protein. This interaction might serve to stabilize the binding of CBP with CREM␣ at the PEPCK promoter as has been proposed for C/EBP␤ and Myb at the Mim-1 promoter (26) . Further work will be required to elucidate the mechanism of cooperation between CREM␣ and C/EBP␣ at the PEPCK promoter.
Our data with CREM␣ DIEDML led us to propose the model shown in Fig. 8 for the mechanism of activation of the PEPCK promoter. In this model, a CREM␣ homodimer binds to the PEPCK CRE. Direct contacts between this homodimer and the basal transcriptional machinery are not required. Phosphorylation of CREM␣ leads to the recruitment of CBP. In addition, the binding of two C/EBP␣ dimers at the P3I and P4 sites appears to be required for transcriptional activation. C/EBP␣ may help to further stabilize the interaction of CBP with CREM␣. The model implies that the characterization of CREM␣ as a transcriptional repressor may pertain only to certain promoters. At some promoters, cooperative interactions with factors such as C/EBP␣ may allow CREM␣ to function as a transcriptional activator.
One prediction that could be made based on our data with the PEPCK promoter is that CREM␣ may be able to activate any promoter containing CRE and C/EBP␣ binding sites. However, the c-fos promoter contains a C/EBP binding site (27) , and it is not activated by CREM␣ DIEDML (Fig. 2B) . The spacing of the C/EBP binding sites and the CREs differ in the c-fos and PEPCK promoters, and this difference may be a critical determinant of whether CREM␣ can serve as an activator. Certainly cooperative activation by CREM␣ and C/EBP␣ is very much dependent on promoter context. It is possible, however, that CREM␣ and C/EBP␣ may cooperatively activate other genes.
